Tecovirimat for the Treatment of Mpox.
Saved in:
| Title: | Tecovirimat for the Treatment of Mpox. |
|---|---|
| Authors: | Zucker J; Division of Infectious Diseases, Columbia University Irving Medical Center, New York., Fischer WA 2nd; Institute for Global Health and Infectious Diseases, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill., Zheng L; Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston., McCarthy C; Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston., Saha PT; Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston., Javan AC; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD., Greninger A; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle., Hamill MM; Johns Hopkins University School of Medicine, Baltimore., Leslie K; Department of Dermatology, University of California, San Francisco, San Francisco., Brooks KM; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora., Berardi J; Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark., Smith D; Department of Medicine, University of California, San Diego, La Jolla., Hosey L; Advancing Clinical Therapeutics Network Coordinating Center, DLH, Atlanta., Aldrovandi G; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles., Ferbas K; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles., Day C; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta., Bender Ignacio RA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle., Bolan R; Los Angeles LGBT Center, Los Angeles., Glesby MJ; Division of Infectious Disease, Weill Cornell Medical College, New York., Landovitz RJ; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles., Luetkemeyer AF; Department of Medicine, University of California, San Francisco, San Francisco., Sierra Madero J; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City., Gandhi RT; Massachusetts General Hospital, Boston., Nachman S; Health Sciences Center, Department of Pediatrics, State University of New York Stony Brook, Stony Brook., Eron J; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill., Currier JS; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles., Wilkin T; Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla. |
| Corporate Authors: | STOMP/A5418 Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2026 Feb 26; Vol. 394 (9), pp. 884-895. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
